Therefore, our further research needs more samples to provide a more accurate subgroup analysis of KEAP1/NFE2L2/CUL3 pathway mutations so as to exhibit a deeper insight into KEAP1/NFE2L2/CUL3 pathway mutation in lung adenocarcinoma progression. Here, NFE2L2 is linked to lung adenocarcinoma.